These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34736341)

  • 21. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
    Jankowska AM; Millward CL; Caldwell CW
    Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer.
    Wang J; Han X; Sun Y
    Sci China Life Sci; 2017 Apr; 60(4):356-362. PubMed ID: 28063009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
    Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
    Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.
    Kommoss FKF; Stichel D; Schrimpf D; Kriegsmann M; Tessier-Cloutier B; Talhouk A; McAlpine JN; Chang KTE; Sturm D; Pfister SM; Romero-Pérez L; Kirchner T; Grünewald TGP; Buslei R; Sinn HP; Mechtersheimer G; Schirmacher P; Schmidt D; Lehr HA; Sahm F; Huntsman DG; Gilks CB; Kommoss F; von Deimling A; Koelsche C
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):97-104. PubMed ID: 31768620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation classifiers: Brain tumors, sarcomas, and what's next.
    Koelsche C; von Deimling A
    Genes Chromosomes Cancer; 2022 Jun; 61(6):346-355. PubMed ID: 35388566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular tumor classification using DNA methylome analysis.
    Sill M; Plass C; Pfister SM; Lipka DB
    Hum Mol Genet; 2020 Oct; 29(R2):R205-R213. PubMed ID: 32657331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation biomarkers and their utility for solid cancer diagnostics.
    Heichman KA; Warren JD
    Clin Chem Lab Med; 2012 Oct; 50(10):1707-21. PubMed ID: 23089699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
    Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.
    Abbou SD; Shulman DS; DuBois SG; Crompton BD
    Pediatr Blood Cancer; 2019 May; 66(5):e27595. PubMed ID: 30614191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
    Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
    Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invited Review: DNA methylation-based classification of paediatric brain tumours.
    Perez E; Capper D
    Neuropathol Appl Neurobiol; 2020 Feb; 46(1):28-47. PubMed ID: 31955441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers.
    Le AV; Szaumkessel M; Tan TZ; Thiery JP; Thompson EW; Dobrovic A
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
    Pickles JC; Stone TJ; Jacques TS
    J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
    van der Pol Y; Mouliere F
    Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
    Maire CL; Fuh MM; Kaulich K; Fita KD; Stevic I; Heiland DH; Welsh JA; Jones JC; Görgens A; Ricklefs T; Dührsen L; Sauvigny T; Joosse SA; Reifenberger G; Pantel K; Glatzel M; Miklosi AG; Felce JH; Caselli M; Pereno V; Reimer R; Schlüter H; Westphal M; Schüller U; Lamszus K; Ricklefs FL
    Neuro Oncol; 2021 Jul; 23(7):1087-1099. PubMed ID: 33508126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors.
    Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ
    J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylated DNA and microRNA in body fluids as biomarkers for cancer detection.
    Ma Y; Wang X; Jin H
    Int J Mol Sci; 2013 May; 14(5):10307-31. PubMed ID: 23681012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.